Association of MGMT-535G>T polymorphism with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy.

被引：0
|
作者：
Chae, Y.
Kim, J.
Sohn, S.
Kang, B.
Ryoo, H.
Bae, S.
Choi, G.
Baek, J.
Kim, Y.
Cho, Y.
机构：
[1] Kyungpook Natl Univ Hosp, Taegu, South Korea
[2] Kyungpook Natl Univ Sch Med, Kyungpook Natl Univ Hosp, Dept Hematol Oncol, Taegu, South Korea
[3] Daegu Catholic Univ Hosp, Taegu, South Korea
[4] Daegu Catholic Univ Coll Med, Dept Internal Med, Div Hematol Oncol, Taegu, South Korea
[5] Ulsan Univ Hosp, Ulsan, South Korea
[6] Dongkuk Univ Hosp, Kyungju, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e14067
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14067
引用
收藏
页数：1
相关论文
共 50 条
  • [31] DEFINITION OF OXALIPLATIN SENSITIVITY IN PATIENTS WITH ADVANCED COLORECTAL CANCER PREVIOUSLY TREATED WITH OXALIPLATIN-BASED THERAPY
    de Gramont, A.
    Chibaudel, B.
    Bourges, O.
    Perez-Staub, N.
    Tournigand, C.
    Maindrault-Goebel, F.
    Andre, T.
    Larsen, A.
    Afchain, P.
    Louvet, C.
    ANNALS OF ONCOLOGY, 2009, 20 : 13 - 13
  • [32] Bevacizumab Plus Irinotecan-Based Therapy in Metastatic Colorectal Cancer Patients Previously Treated With Oxaliplatin-Based Regimens
    Yildiz, Ramazan
    Buyukberber, Suleyman
    Uner, Aytug
    Yamac, Deniz
    Coskun, Ugur
    Kaya, Ali Osman
    Ozturk, Banu
    Yaman, Emel
    Benekli, Mustafa
    CANCER INVESTIGATION, 2010, 28 (01) : 33 - 37
  • [33] Bevacizumab plus irinotecan-based therapy in metastatic colorectal cancer patients previously treated with oxaliplatin-based regimen
    Yildiz, R.
    Buyukberber, S.
    Uner, A.
    Yamac, D.
    Coskun, U.
    Kaya, A. O.
    Ozturk, B.
    Yaman, E.
    Benelkli, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 143 - 143
  • [34] Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy for metastatic colorectal cancer.
    Rubbia-Brandt, L
    Audard, V
    Sartoretti, P
    Roth, AD
    Brezault, C
    Lecharpentier, M
    Dousset, B
    Morel, P
    Soubrane, O
    Chaussade, S
    Mentha, G
    Terris, B
    HEPATOLOGY, 2003, 38 (04) : 696A - 696A
  • [35] PKM2 as a biomarker for sensitivity to oxaliplatin-based chemotherapy in metastatic colorectal cancer (mCRC).
    Papadaki, C.
    Saridaki, Z.
    Tzardi, M.
    Sfakianaki, M.
    Sfakiotaki, G.
    Trypaki, M.
    Messaritakis, I.
    Mavroudis, D.
    Georgoulias, V.
    Sougklakos, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [36] Association of a polymorphism in amphiregulin with worse prognosis in metastatic colorectal cancer patients treated with cetuximab.
    Wilson, Peter M. D.
    Wakatsuki, Takeru
    Loupakis, Fotios
    Zhang, Wu
    Yang, Dongyun
    Stintzing, Sebastian
    Ning, Yan
    Volz, Nico Benjamin
    El-Khoueiry, Rita Elie
    Li, Joseph Ethan
    Labonte, Melissa Janae
    Sunakawa, Yu
    Maus, Martin K. H.
    Ladner, Robert D.
    Barzi, Afsaneh
    Iqbal, Syma
    El-Khoueiry, Anthony B.
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] A retrospective cohort study of metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy, with an exploratory analysis of changing serum carcinoembryonic antigen levels
    Ng, Say Liang
    Burns, William I.
    Snyder, Raymond D.
    Newnham, Genni M.
    Mclachlan, Sue-Anne
    Liew, Danny
    Dowling, Anthony J.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 (02) : 172 - 179
  • [38] Basal sFAS/sFASL ratio and FAS polymorphisms, as a prognostic marker, in advanced colorectal carcinoma patients (ACRC), treated with oxaliplatin-based chemotherapy.
    Gascon, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 278S - 278S
  • [39] Cetuximab with oxaliplatin and capecitabine (CAPOX)in patients with metastatic colorectal cancer (mCRC) refractory to standard chemotherapy.
    Grothe, W
    Arnold, D
    Peinert, S
    Voigt, W
    Loeffler, LM
    Siewczynski, R
    Steps, G
    Boehme, J
    Graeven, U
    Schmoll, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 288S - 288S
  • [40] Neutropenia in colorectal cancer treated with oxaliplatin-based hyperthermic intraperitoneal chemotherapy: An observational cohort study
    Peter H Cashin
    Lana Ghanipour
    Malin Enblad
    David L Morris
    World Journal of Gastrointestinal Oncology, 2020, (05) : 549 - 558
12345